Cipta Sarana Medika Tbk. vs Hensel Davest Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp65 (market cap 163.22B, 567.1K 24h volume), while Hensel Davest Indonesia Tbk. trades at Rp51 (market cap 77.76B, 1.46M 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 2.1× Hensel Davest Indonesia Tbk.'s market cap, and Hensel Davest Indonesia Tbk. is more actively traded (1.46M versus 567.1K). Which is the better fit depends on your goals.
| DKHH | HDIT | |
|---|---|---|
Market Cap | 163.22B | 77.76B |
Volume | 567.1K | 1.46M |
Lot | 5.67K | 14.64K |
Turnover | 36.31M | 74.68M |
Average Price | 64.02 | 51 |
Value | 36.31M | 74.68M |
Indicative Equilibrium Price | 64 | 51 |
Indicative Equilibrium Volume | 110.6K | 846.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Hensel Davest Indonesia Tbk (the Company) was established on January 7, 2013 based on Notarial Deed. 01 from Notary Soewandi Michael Barya Sugiyo SH., M.Kn.
Read more on HDIT →